The goal is to make at least 300 million doses of a coronavirus vaccine that could be available as early as October.
FRIDAY, May 22, 2020 (HealthDay News) -- The U.S. Department of Health and Human Services said Thursday it would provide up to $1.2 billion to the drug company AstraZeneca to develop a potential coronavirus vaccine from a lab in Oxford, U.K.
The fourth, and largest, vaccine research agreement funds a clinical trial of the potential vaccine in the United States this summer with about 30,000 volunteers, The New York Times reported.
The goal? To make at least 300 million doses that could be available as early as October, the HHS said in a statement.